Although an opposing role of Th17 and IL17A responses in cancer development is becoming evident, accumulating data from mouse studies suggest that Th17 cells can cause more significant tumor regression compared with Th1 cells (63, 76–78). This evidence concerns the gene IL17A and neoplasm.